| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 40.68B | 28.29B | 27.81B | 26.88B | 37.48B |
| Gross Profit | 32.34B | 19.40B | 18.28B | 17.56B | 27.83B |
| EBITDA | 18.71B | 11.91B | 9.88B | 9.07B | 14.23B |
| Net Income | 12.03B | 10.39B | 8.76B | 8.07B | 11.65B |
Balance Sheet | |||||
| Total Assets | 753.80B | 721.16B | 695.85B | 611.68B | 597.22B |
| Cash, Cash Equivalents and Short-Term Investments | 348.18B | 286.24B | 244.33B | 230.94B | 225.64B |
| Total Debt | 389.92B | 196.54B | 215.43B | 183.59B | 187.54B |
| Total Liabilities | 632.70B | 590.91B | 573.82B | 496.42B | 484.63B |
| Stockholders Equity | 121.06B | 130.18B | 121.96B | 115.17B | 112.50B |
Cash Flow | |||||
| Free Cash Flow | -36.24B | 53.96B | 26.50B | 61.94B | -41.61B |
| Operating Cash Flow | -35.54B | 54.73B | 27.10B | 62.50B | -41.19B |
| Investing Cash Flow | 3.34B | -14.26B | -24.09B | -19.13B | 13.81B |
| Financing Cash Flow | 25.89B | -10.36B | 7.70B | -21.01B | 35.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$139.65B | 10.56 | 8.83% | 0.97% | 64.00% | 112.84% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | HK$148.64B | 9.05 | 9.55% | 3.83% | 51.04% | 24.56% | |
59 Neutral | HK$416.52B | 12.45 | 10.28% | 2.05% | 62.72% | 29.18% | |
59 Neutral | HK$125.75B | 7.38 | 8.68% | 2.89% | 61.94% | 127.55% | |
57 Neutral | HK$171.64B | 9.77 | 8.46% | 2.92% | 10.82% | 55.25% | |
53 Neutral | HK$168.58B | 9.66 | 10.70% | 2.80% | 36.57% | 77.14% |